Jeffrey LaRose, Chief Scientific Officer at HeartWare International, Inc. (HTWR), sold 337 shares at $89.92 ($30K) on 2015-02-25, disclosed to the SEC on 2015-02-26.
Scheduled sale ($30k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| HTWR | SELL | 2016-02-09 | $20K | — | Filing → |
| HTWR | SELL | 2015-12-23 | $57K | — | Filing → |
| HTWR | SELL | 2015-02-10 | $42K | — | Filing → |